|
|
Article: Alternative systems will play a greater role in biopharmaceutical delivery by the year 2005.
- Article from:
- The BBI Newsletter
- Article date:
- November 1, 1996
CopyrightCOPYRIGHT 1996 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Liposomes, MAbs, transdermal patches and other approaches eyed for growth
Delivering drugs by alternative routes is becoming increasingly important in the pharmaceutical industry. Drug companies, faced with generic competition and the advent of new biopharmaceutical compounds, need new methods of introducing their products into the body in a targeted and controlled manner. Such new methods include liposomes, monoclonal antibodies, needleless injections, oral controlled-release drugs, polymer-based, pulmonary, transdermal, and transmucosal delivery systems. The market for alternative drug delivery systems (ADDS) has experienced especially strong growth due to ...